Drug Shortage Report for HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
Report ID | 102491 |
Drug Identification Number | 02209721 |
Brand name | HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ |
Common or Proper name | Hepain Sodium |
Company Name | B. BRAUN MEDICAL INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE HEPARIN SODIUM |
Strength(s) | 5G 10000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250mL |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-12-05 |
Estimated end date | 2020-11-02 |
Actual end date | 2020-11-13 |
Shortage status | Resolved |
Updated date | 2020-11-18 |
Company comments | Product now available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 824 TWELFTH AVENUE BETHLEHEM, PENNSYLVANIA UNITED STATES 18018 |
Company contact information | Cindy Katsempris; cindy.katsempris@bbraunusa.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-01-07 | French | Compare |
v1 | 2020-01-07 | English | Compare |